Evolution of the Average Target: Galectin Therapeutics Inc.

Evolution of the Target Price: Galectin Therapeutics Inc.

Changes in Analyst Recommendations: Galectin Therapeutics Inc.

d.4AAZO41211_jU0IP87TfbZ-QGw54zj3LEis7HyWfwGU.uWMrDs44lgmqKyFLnMbvCqvgbn8zuGT_SFtPSxHF9RLXcH10xyWSbYIACw~586d54e6f253b1d5e8d0e519d955672e

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +214.29%
+24.99%
+11.38%
+29.66%
+16.86%
+50.89%
+20.22%
-10.56%
+1.85%
+8.69%
Average +36.83%
Weighted average by Cap. +20.57%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.480USD
Average target price
11.00USD
Spread / Average Target
+216.09%
High Price Target
11.00USD
Spread / Highest target
+216.09%
Low Price Target
11.00USD
Spread / Lowest Target
+216.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.480USD
Average target price
11.00USD
Spread / Average Target
+216.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GALT Stock
  4. Consensus Galectin Therapeutics Inc.